Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Bogazzi

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective studyFausto Bogazzi, Luigi Battolla, Cheti Spinelli, et al.
The Journal of Clinical Endocrinology and Metabolism|July 18, 2020
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early ThyroidectomyDaniele Cappellani, Piermarco Papini, Agostino Maria Di Certo, et al.
Journal of Neuro-Oncology|November 29, 2015
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomasMarco Losa, Fausto Bogazzi, Salvo Cannavo, et al.
European Journal of Endocrinology|August 17, 2016
Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegalyChiara Sardella, Daniele Cappellani, Claudio Urbani, et al.
European Journal of Endocrinology|January 8, 2011
Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapyGherardo Mazziotti, Teresa Porcelli, Fausto Bogazzi, et al.
European Journal of Endocrinology|September 13, 2008
Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control studyLuca Manetti, Arthur B Parkes, Isabella Lupi, et al.
Endocrine Connections|January 10, 2024
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysisAntonella Giampietro, Sabrina Chiloiro, Claudio Urbani, et al.
Journal of Endocrinological Investigation|November 12, 2025
Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experienceLaura Pierotti, Elena Pardi, Chiara Sardella, et al.
Thyroid : Official Journal of the American Thyroid Association|July 17, 2021
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody TestsDaniele Cappellani, Giuseppina De Marco, Eleonora Ferrarini, et al.
Obesity Surgery|June 1, 2012
Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric bandingGiulia Galli, Aldo Pinchera, Paolo Piaggi, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective studyFausto Bogazzi, Luigi Battolla, Cheti Spinelli, et al.
The Journal of Clinical Endocrinology and Metabolism|July 18, 2020
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early ThyroidectomyDaniele Cappellani, Piermarco Papini, Agostino Maria Di Certo, et al.
Journal of Neuro-Oncology|November 29, 2015
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomasMarco Losa, Fausto Bogazzi, Salvo Cannavo, et al.
European Journal of Endocrinology|August 17, 2016
Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegalyChiara Sardella, Daniele Cappellani, Claudio Urbani, et al.
European Journal of Endocrinology|January 8, 2011
Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapyGherardo Mazziotti, Teresa Porcelli, Fausto Bogazzi, et al.
European Journal of Endocrinology|September 13, 2008
Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control studyLuca Manetti, Arthur B Parkes, Isabella Lupi, et al.
Endocrine Connections|January 10, 2024
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysisAntonella Giampietro, Sabrina Chiloiro, Claudio Urbani, et al.
Journal of Endocrinological Investigation|November 12, 2025
Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experienceLaura Pierotti, Elena Pardi, Chiara Sardella, et al.
Thyroid : Official Journal of the American Thyroid Association|July 17, 2021
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody TestsDaniele Cappellani, Giuseppina De Marco, Eleonora Ferrarini, et al.
Obesity Surgery|June 1, 2012
Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric bandingGiulia Galli, Aldo Pinchera, Paolo Piaggi, et al.
Pageof 9